Alessia Aloisi

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

The role of novel biomarker HE4 in endometrial cancer: a case control prospective study

Roberto Angioli, Francesco Plotti, Stella Capriglione et al. · Tumor Biology · 2012 · 102 citations

Medicine, Gynecology, Oncology +17

Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer

Roberto Angioli, Francesco Plotti, Roberto Montera et al. · Gynecologic Oncology · 2012 · 90 citations

Medicine, Oncology, Surgery +13

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers

Jennifer Bergstrom, Alessia Aloisi, Shannon D. Armbruster et al. · Gynecologic Oncology · 2018 · 87 citations · Full text

Medicine, Gynecology, Surgery +9